Introduction
============

Much concern has been raised about the effects of anesthetic drugs on cognition. The proportion of postoperative cognitive dysfunction (POCD) after surgery is as high as 10%--62%, which seriously affects the quality of life of patients.[@b1-lra-12-001] POCD may manifest as impairment in attention, memory, language or executive functions following surgery, and can persist for weeks, months, or longer with varying severity. POCD can be mild and only diagnosed by psychometric assessment using specific neuropsychological tests.[@b2-lra-12-001] Postoperatively, patients may experience some difficulty in resuming their normal activities, forget appointments, names, and phone numbers, and discover problems in recalling recent events. Such deterioration in cognitive function may have serious consequences on the patient's ability to work.[@b3-lra-12-001]

Multiple clinical trials have attempted to differentiate the effect of general vs regional anesthesia on cognitive function. While most of the studies showed no difference in postoperative cognitive function between regional and general anesthesia, some trials showed a significant difference in postoperative cognitive outcomes between the two anesthetic techniques.[@b4-lra-12-001]--[@b8-lra-12-001]

The pathogenesis of cognitive dysfunction following local anesthesia can be attributed to its neurotoxic side effects. Local anesthetics are known to be neurotoxic in a dose-dependent manner. However, it has to be noted that the exact pathway of cell death depends on the concentration of local anesthetic. For example, in Jurkat cells (immortalized lymphocytes), clinically relevant concentrations of lidocaine induced apoptosis, while higher concentrations induced necrosis and unspecific cell death.[@b9-lra-12-001],[@b10-lra-12-001]

There is a large amount of evidence that the toxicity among local anesthetics varies. This evidence suggests that lidocaine is more toxic than equipotent concentrations of bupivacaine.[@b11-lra-12-001],[@b12-lra-12-001] However, this is still up for debate as other studies have shown that there is no difference in toxicity between local anesthetics.[@b13-lra-12-001]

The aim of this work was to study the effect of local anesthesia with lidocaine vs bupivacaine on cognitive function.

Patients and methods
====================

Study design and population
---------------------------

This was a prospective randomized trial carried out on 61 patients undergoing elective cataract surgery. Patients were randomly assigned to one of two groups; the first group received local anesthesia with lidocaine 2% and the second group received local anesthesia with bupivacaine 0.5%. Randomization was carried out using a closed opaque envelope technique where the anesthetist picked up a sealed envelope which contained a sheet of paper with the name of the group to which the patient had been randomized. The patient was scheduled to whichever group was written on the paper. The patients were recruited during the period between June 2018 and August 2018 from the Ophthalmology outpatient clinics of Benisuef University Hospital.

Inclusion criteria
------------------

Out of 61 patients undergoing elective cataract surgery by phacoemulsification under local anesthesia, 28 patients received lidocaine 2% and 33 patients received bupivacaine 0.5%. The subjects provided signed, written informed consent to participate and if cataract markedly affected the vision of the patient, written informed consent was obtained from a family member. The study was approved by the local ethics committee of Faculty of Medicine, Benisuef University. The study was conducted in accordance with the Declaration of Helsinki. The study was registered in the Pan African Clinical Trial Registry with identification number PACTR201806003395974.

Exclusion criteria
------------------

Exclusion criteria: patients with major language disturbance or auditory impairment affecting their ability to complete testing, patients with preexisting cognitive, psychiatric or central nervous system disorders, patients with nystagmus, allergy to local anesthetics, intravenous sedation, any coexisting ocular conditions that could affect the scoring system for local anesthesia such as ptosis, ocular movement abnormality, reduced corneal sensation, or facial nerve palsy, inability to understand the information about the study or if the patient refused the local anesthesia technique.

All patients included in the study were subjected to the following
------------------------------------------------------------------

1.  Cognitive assessment: cognitive assessment for all patients was done preoperatively and 1 week postoperatively using paired associate learning test (PALT) and category verbal fluency (VF) test (animal category). PALT is used to assess verbal memory. In this test, the examiner lists ten associated pairs in front of the candidate. These pairs contain six compatible semantically related pairs and four incompatible semantically unrelated pairs. After 1 minute, the candidate is given the first word of the pairs and is asked to recall the second word. The test is repeated three times. Each correct compatible pair has a score of 0.5, while each correct incompatible pair has a score of 1. The total score ranges from 0 to 21.[@b14-lra-12-001] Category VF test is used to assess attention and executive function. In this test, the patient is asked to name as many animals as possible within 1 minute. Each animal he names, has a score of 1.[@b15-lra-12-001]

2.  Anesthetic technique: anesthesia during cataract surgery was performed for all patients by the same anesthesiologist using the same anesthetic technique. The included 61 patients in the study were divided into two groups; the first group included 28 patients injected with lidocaine 2% with total volume 7 mL and the second group included 33 patients injected with bupivacaine 0.5% with the same volume, 7 mL, hyaluronidase 15 IU was added to the drugs before injection, all patients were allocated using random number tables. All patients were guided to the preparation room, venous access was obtained using antiseptic technique, standard monitoring was applied (electrocardiogram, oxygen saturation, non-invasive blood pressure), no premedication was given to the patients, only psychological reassurance, amethocaine eye drops were instilled to provide topical anesthesia to all patients. Blocks were performed by one anesthetist. In all cases, a peribulbar injection technique was used with a 25 mm 25 G needle using complete antiseptic technique, patients were injected with a volume of 4 mL inferolaterally after negative aspiration with the patients looking straight ahead and 3 mL through the medial canthus. A total of 7 mL of local anesthetic solution was injected in all patients. The inferolateral injection was performed before the medial canthal injection. Digital pressure was applied for 5 minutes which was released every 30 seconds for 5 seconds. The quality of the block was assessed every 2 minutes by an observer rather than the anesthetist blinded to the drugs. The motor functions (levator, orbicularis oculi and the extraocular muscles; up, down, medial, lateral) and sensory functions (digital spear pressure at limbus and topical anesthetic sting) were evaluated using Ocular Anaesthetic Scoring System (OASS).[@b16-lra-12-001] Intraoperative pain was assessed using the visual analogue pain (VAP) scale.[@b17-lra-12-001]

3.  Surgical technique: cataract surgery was performed for all patients by the same surgeon using the same surgical technique. Surgery was performed after prior conjunctival and periocular cleansing with povidone iodine 5% and 10% solution, respectively. In all patients, a 2.8 mm clear corneal incision was made at the most curved axis. Phacoemulsification was performed with implantation of an acrylic intraocular lens into the capsular bag through a sutureless incision.

Statistical methods
-------------------

The sample size calculation was done using G^\*^Power version 3.1.9.2 Software based on our pretrial pilot study. The probability of type I error (α) was 5%, and the power (1--β) was 90%. A total of 61 participants were required for statistical significance. The data were coded and entered using SPSS version 18. Descriptive statistics were reported as mean ± SD and number (%) for categorical variables. Student's *t*-test was used for comparison between means of two unpaired groups of quantitative variables. Paired sample *t*-test was used for comparison between means of two paired groups of quantitative variables. Chi-squared test was used for comparison between two groups of categorical data. Mixed ANOVA test was used for comparing paired data in two unpaired groups. The probability/significance value (*P*-value) ≥0.05 was not statistically significant and \<0.05 was statistically significant.

Results
=======

The mean age of patients in lidocaine group (n=28) was 51.29±11.42 years, while the mean age of patients in bupivacaine group (n=33) was 55.97±11.35 years. In lidocaine group, 46.4% (n=13) of the patients were males and 53.6% (n=15) were females. Regarding patients in bupivacaine group, 33.3% (n=11) were males and 66.7% (n=22) were females. There was no statistically significant difference between both groups in either age (*P*-value =0.11) or sex (*P*-value =0.297) ([Table 1](#t1-lra-12-001){ref-type="table"}).

Regarding motor score of OASS, patients in lidocaine group were found to have significantly higher mean values in the total motor score than patients in bupivacaine group (*P*-value \<0.001), while there was no statistically significant difference between patients in lidocaine group and those in bupivacaine group in the total sensory score of OASS (*P*-value =0.168) or VAP scale score (*P*-value =0.787) ([Table 2](#t2-lra-12-001){ref-type="table"}).

Regarding the total score of PALT in patients in lidocaine group, there was a statistically significant difference between the mean value of preoperative PALT (11.29±4.77) and postoperative PALT (10.27±5.63) (*P*-value =0.004). In bupivacaine group, there was a less statistically significant difference between the mean value of preoperative PALT (10.29±5.05) and postoperative PALT (9.82±4.96) (*P*-value =0.021). On comparing lidocaine and bupivacaine groups in pre and postoperative PALT scores, there was no statistically significant difference between both groups (*P*-value =0.579) ([Table 3](#t3-lra-12-001){ref-type="table"}).

Regarding the total score of VF in patients in lidocaine group, there was a statistically significant difference between the mean value of preoperative VF (9.57±2.24) and postoperative VF (8.54±1.43) (*P*-value =0.002). In bupivacaine group, there was a less statistically significant difference between the mean value of preoperative VF (9.06±2.46) and postoperative VF (8.58±2.02) (*P*-value =0.037). On comparing lidocaine and bupivacaine groups regarding pre and postoperative VF scores, there was no statistically significant difference between both groups (*P*-value =0.642) ([Table 4](#t4-lra-12-001){ref-type="table"}).

Discussion
==========

POCD has gained much attention over the last years. Multiple clinical trials have attempted to differentiate the effect of regional vs general anesthesia on postoperative cognitive function. Nevertheless, the importance of postoperative cognitive decline has long been debated. Descriptions such as "transient", "subtle", and "subclinical" have been used to minimize the importance of these changes to clinicians, patients, and their families. POCD was thought to be a reversible condition in the majority of elderly patients undergoing surgery. However, a significant positive correlation between postoperative cognitive decline and long-term cognitive dysfunction was recently demonstrated.[@b18-lra-12-001] Such correlation suggests that POCD may serve either as a marker of brain injury, increased susceptibility to brain injury, decreased reserve capacity, or inability to recover or tolerate similar injury (plasticity).[@b19-lra-12-001]

A systematic review was done by Davis et al[@b8-lra-12-001] to compare the risk of POCD following general vs regional anesthesia. Sixteen studies met inclusion criteria and were included in the final analysis. The investigators found that only 3 studies showed some differences in postoperative cognitive function between regional and general anesthesia, while the remaining 13 showed no differences between regional and general anesthesia.

The variability of the results of various studies could largely be attributed to the absence of a standard POCD defi-nition, the disparity in targeted population, the heterogeneity of procedures used to measure cognitive deficits, and the different methods used for statistical analysis. In addition, the complex interaction of the potential confounders can make it difficult to isolate the influence of anesthesia itself.[@b20-lra-12-001],[@b21-lra-12-001]

Although many studies were done to compare the risk of POCD following general vs local anesthesia, no comparative studies have been done to investigate the effect of various local anesthetics on cognitive function. Our study aimed at determining which of the two local anesthetic drugs (lidocaine vs bupivacaine) had a worse effect on cognitive function in patients undergoing elective cataract surgery. Our results revealed that both lidocaine and bupivacaine caused POCD in verbal memory, attention, and executive function. Lidocaine was found to be worse than bupivacaine but the difference was not statistically significant.

Our findings can be explained by the neurotoxic effect of local anesthetics. Local anesthetics are known to induce apoptosis, unspecific cell death, and necrosis. There are possible mechanisms that cause apoptosis in neurons. Local anesthetics can lead to fragmentation of DNA and disruption of the membrane potential in mitochondria. This results in the uncoupling of the oxidative phosphorylation, which subsequently causes the release of cytochrome *c* and the initiation of the caspase pathway leading to apoptosis.[@b9-lra-12-001],[@b10-lra-12-001]

The reported postoperative cognitive decline in the present study can be attributed to the combined effect of surgery and local anesthesia. So, further studies are needed to clarify the effect of surgery alone on cognitive function.

The main limitation of this work was the lack of measurement of markers of neuronal degeneration that could help to compare the intensity of neurotoxicity between the two anesthetic drugs. Further studies should be conducted on a larger number of patients and for a longer duration to clarify if POCD following local anesthesia is reversible or not. Additionally, the effect of surgery alone on cognitive function should be tested. Closer observation of oculomotor function following local anesthesia for a longer period should be done.

Conclusion
==========

Both lidocaine and bupivacaine caused postoperative impairment in verbal memory, attention, and executive function due to their neurotoxic side effects. Lidocaine was found to be worse than bupivacaine but the difference was not statistically significant. Lidocaine significantly affected motor function compared to bupivacaine in patients undergoing elective cataract surgery.
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###### 

Demographics of patients in lidocaine and bupivacaine groups

  Demographics               Lidocaine group (n=28)   Bupivacaine group (n=33)   *P*-value    
  -------------------------- ------------------------ -------------------------- ------------ -------
  Age in years \[mean SD\]   51.29 (11.42)            55.97 (11.35)              0.11         
  Sex                        Male \[n (%)\]           13 (46.4%)                 11 (33.3%)   0.297
  Female \[n (%)\]           15 (53.6%)               22 (66.7%)                              

**Note:** *P*-value ≥0.05 (non-significant).

###### 

Assessment of motor functions, sensory function, and intraoperative pain in lidocaine vs bupivacaine group

  Ocular anaesthetic scoring system and intraoperative pain   Lidocaine group (n=28)          Bupivacaine group (n=33)   *P*-value                                            
  ----------------------------------------------------------- ------------------------------- -------------------------- ---------------------------------------------------- ----------------------------------------------------
  Motor function\[mean SD\]                                   Levator (0--2)                  0.86                       0.33                                                 \<0.001[\*](#tfn3-lra-12-001){ref-type="table-fn"}
  Orbicularis oculi (0--2)                                    0.75                            0.33                       0.003[\*](#tfn3-lra-12-001){ref-type="table-fn"}     
  EOM-up (0--2)                                               0.5                             0.30                       0.154                                                
  EOM-down (0--2)                                             0.36                            0.42                       0.6                                                  
  EOM-lateral (0--2)                                          0.54                            0.30                       0.07                                                 
  EOM-medial (0--2)                                           0.39                            0.24                       0.218                                                
  Total motor (0--12)                                         3.39                            1.94                       \<0.001[\*](#tfn3-lra-12-001){ref-type="table-fn"}   
  Sensory function \[mean SD\]                                Digital spear pressure (0--1)   0.21                       0.15                                                 0.533
  Topical anesthetic sting (0--1)                             0.11                            0.00                       0.083                                                
  Total sensory (0--2)                                        0.32                            0.15                       0.168                                                
  Pain \[mean SD\]                                            VAP scale (0--10)               0.07                       0.09                                                 0.787

**Notes:** *P*-value ≥0.05 (non-significant),

*P*-value \<0.05 (significant).

**Abbreviations:** EOM, extraocular muscles; VAP, visual analogue pain.

###### 

Pre and postoperative PALT scores in lidocaine vs bupivacaine group

  Cognitive assessment   Preoperative assessment   Postoperative assessment   *P*-value                                          *P*-value between groups                           
  ---------------------- ------------------------- -------------------------- -------------------------------------------------- -------------------------------------------------- -------
  PALT \[mean SD\]       Lidocaine group           11.29 (4.77)               10.27 (5.63)                                       0.004[\*](#tfn5-lra-12-001){ref-type="table-fn"}   0.579
  Bupivacaine group      10.29 (5.05)              9.82 (4.96)                0.021[\*](#tfn5-lra-12-001){ref-type="table-fn"}                                                      

**Note:**

*P*-value \<0.05 (significant).

**Abbreviation:** PALT, paired associate learning test.

###### 

Pre and postoperative VF scores in lidocaine vs bupivacaine group

  Cognitive assessment   Preoperative assessment   Postoperative assessment   *P*-value                                          *P*-value between groups                           
  ---------------------- ------------------------- -------------------------- -------------------------------------------------- -------------------------------------------------- -------
  VF \[mean SD\]         Lidocaine group           9.57 (2.24)                8.54 (1.43)                                        0.002[\*](#tfn7-lra-12-001){ref-type="table-fn"}   0.642
  Bupivacaine group      9.06 (2.46)               8.58 (2.02)                0.037[\*](#tfn7-lra-12-001){ref-type="table-fn"}                                                      

**Note:**

*P*-value \<0.05 (significant).

**Abbreviation:** VF, verbal fluency.
